OVILIS PASTOVAX SUSPENSION INJECTABLE POUR OVINS
OVILIS PASTOVAX SUSPENSION INJECTABLE POUR OVINS
Authorised
- Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated
- Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
- Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
- Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
- Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
- Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
- Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
- Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
- Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
Product identification
Medicine name:
OVILIS PASTOVAX SUSPENSION INJECTABLE POUR OVINS
Active substance:
- Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated
- Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
- Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
- Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
- Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
- Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
- Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
- Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
- Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
Target species:
-
Sheep
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated1000000000.00/Organisms2.00millilitre(s)
-
Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated1000000000.00/Organisms2.00millilitre(s)
-
Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated1000000000.00/Organisms2.00millilitre(s)
-
Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated1000000000.00/Organisms2.00millilitre(s)
-
Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated1000000000.00/Organisms2.00millilitre(s)
-
Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated1000000000.00/Organisms2.00millilitre(s)
-
Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated1000000000.00/Organisms2.00millilitre(s)
-
Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated1000000000.00/Organisms2.00millilitre(s)
-
Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated1000000000.00/Organisms2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Sheep
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI04AB02
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/5565060 1/2008
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 14/03/2025
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 7/04/2025